The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 2019 (COVID-19). This virus has become a global pandemic with unprecedented mortality and morbidity along with attendant financial and economic crises. Furthermore, COVID-19 can easily be tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyagbemi, Ademola Adetokunbo, Ajibade, Temitayo Olabisi, Aboua, Yapo Guillaume, Gbadamosi, Idayat Titilayo, Adedapo, Aduragbenro Deborah A., Aro, Abimbola Obemisola, Adejumobi, Olumuyiwa Abiola, Thamahane-Katengua, Emma, Omobowale, Temidayo Olutayo, Falayi, Olufunke Olubunmi, Oyagbemi, Taiwo Olaide, Ogunpolu, Blessing Seun, Hassan, Fasilat Oluwakemi, Ogunmiluyi, Iyanuoluwa Omolola, Ola-Davies, Olufunke Eunice, Saba, Adebowale Benard, Adedapo, Adeolu Alex, Nkadimeng, Sanah Malomile, McGaw, Lyndy Joy, Kayoka-Kabongo, Prudence Ngalula, Yakubu, Momoh Audu, Oguntibeju, Oluwafemi Omoniyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654738/
https://www.ncbi.nlm.nih.gov/pubmed/34903929
http://dx.doi.org/10.14202/vetworld.2021.2705-2713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654738/
https://www.ncbi.nlm.nih.gov/pubmed/34903929
http://dx.doi.org/10.14202/vetworld.2021.2705-2713

Ejemplares similares